Product Information
KETOROLAC 0.5% OPHTH SOLUTION is a generic product labeled by SOLA Pharmaceuticals LLC, priced at $1.3384 per ML under NDC 70512079010. Its NADAC has been published 117 times since Jul 10, 2024.
FDA first approved this application on Mar 26, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
5 mg/mL
Manufacturer
SOLA Pharmaceuticals LLCNDC
70512079010
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA218204FDA Approved
3/26/2024
TE Code
AT
On Market Since
4/15/2024
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 0.5% OPHTH SOLUTION has been published 117 times since Jul 10, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3384 per ML |
|---|---|
| All-time high | $1.4384 (Sep 10, 2025) |
| All-time low | $1.1071 (Dec 18, 2024) |
| 52-week high | $1.4168 |
| 52-week low | $1.1713 |
| Median price | $1.2709 |
| Average price | $1.2639 |
| Largest weekly change | +16.6% (Mar 19, 2025) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SOLA Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ketorolac tromethamine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cyclooxygenase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOROLAC 0.5% OPHTH SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 0.5% OPHTH SOLUTION, manufactured by SOLA Pharmaceuticals LLC, is $1.3384 per ML (NDC 70512079010), effective Sep 30, 2026.
How has the price of KETOROLAC 0.5% OPHTH SOLUTION changed over time?
Over the history we have for it, the NADAC for KETOROLAC 0.5% OPHTH SOLUTION has held within roughly two percent of its current level. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for KETOROLAC 0.5% OPHTH SOLUTION?
Since Jul 10, 2024, the NADAC for KETOROLAC 0.5% OPHTH SOLUTION has ranged from a low of $1.1071 (Dec 18, 2024) to a high of $1.4384 (Sep 10, 2025), with a median of $1.2709 per ML.
Are there cheaper alternatives to KETOROLAC 0.5% OPHTH SOLUTION?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as KETOROLAC 0.5% OPHTH SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures KETOROLAC 0.5% OPHTH SOLUTION?
KETOROLAC 0.5% OPHTH SOLUTION (NDC 70512079010) is labeled by SOLA Pharmaceuticals LLC, and CMS classifies it as a generic product.